Regulus Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Regulus Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Regulus Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.42M, a 149% increase year-over-year.
  • Regulus Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.31M, a 192% increase year-over-year.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.8M, a 28.7% increase from 2022.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.18M, a 25.5% decline from 2021.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.92M, a 11.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.8M +$624K +28.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $2.18M -$746K -25.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $2.92M +$309K +11.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $2.61M +$326K +14.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $2.29M -$3.15M -57.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $5.44M -$2.2M -28.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $7.64M -$5.23M -40.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $12.9M -$2.5M -16.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $15.4M +$8.33M +118% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $7.04M +$3.62M +106% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 $3.42M +$1.87M +121% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $1.55M +$725K +87.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-19
2011 $825K +$222K +36.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $603K Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.